Abstract:Background: Novel treatments such as monotherapy and combined immunotherapy significantly extend overall survival (OS) for hepatocellular carcinoma (HCC) patients, but HCC is susceptible to treatment resistance during long-term therapy. The resistance mechanism to targeted drugs in HCC remains ambiguous, making research on HCC drug resistance targets crucial for the development of precision medicine. Objectives: To investigate the transcriptional features, biological functions and potential clinical value of the tyrosine kinase inhibitor (TKI)-resistant gene ZNF687 in HCC. Material and methods: The TKI-resistant genes of HCC were identified using clustered regularly interspaced short palindromic repeats (CRISPR) in vitro screening. Then, the dependence of HCC cell lines on ZNF687 was investigated in silico. We collected global mRNA datasets of HCC tissue, integrated the mRNA expression characteristics of ZNF687 in HCC and explored the impact of ZNF687 on HCC patient prognoses using the Kaplan-Meier method (in silico). The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways analyses were then conducted, and a connectivity map and molecular docking technology were applied to find the underlying agent opposing ZNF687. Results: In vitro, the guide RNA corresponding to ZNF687 was weakly detected in HCC cells, and ZNF687 deficiency was found to inhibit growth in HCC cell lines. ZNF687 mRNA was overexpressed and had a high discriminatory ability for HCC in 2,975 HCC samples, contrasting with 2,340 non-HCC samples. Moreover, an excessive ZNF687 transcript level was related to a worse overall survival (OS) prognosis. Histone modification, spliceosome, transcription coregulator activity, and nucleocytoplasmic transport were the most significant pathways for ZNF687 differential-related gene enrichment. Chaetocin was found to be a candidate compound and presented a strong affinity to ZNF687. Conclusions: ZNF687 represents a TKI-resistant and growth-dependent gene for HCC, the overexpression of which indicates poor OS for HCC patients. Additionally, ZNF687 is expected to be a druggable target for overcoming TKI resistance, and chaetocin may be a candidate therapeutic compound for ZNF687.

KCNK9 mediates the inhibitory effects of genistein on hepatic metastasis from colon cancer

Genistein Suppresses Flt4 and Inhibits Human Colorectal Cancer Metastasis

Inhibitory Effects of Genistein on Metastasis of Human Hepatocellular Carcinoma.

Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1.

Genistein Inhibits Invasive Potential of Human Hepatocellular Carcinoma by Altering Cell Cycle, Apoptosis, and Angiogenesis

Genistein Inhibits Invasion and Migration of Colon Cancer Cells by Recovering WIF1 Expression.

Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-κB) pathway

Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer

Ginsenoside Compound K Attenuates Metastatic Growth of Hepatocellular Carcinoma, Which is Associated with the Translocation of Nuclear Factor-Κb P65 and Reduction of Matrix Metalloproteinase-2/9.

Genistein Inhibits Proliferation and Metastasis in Human Cervical Cancer Cells through the Focal Adhesion Kinase Signaling Pathway: A Network Pharmacology-Based In Vitro Study in HeLa Cells

Genistein reinforces the inhibitory effect of Cisplatin on liver cancer recurrence and metastasis after curative hepatectomy.

Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines

Effects of Genistein on biological behavior of human hepatocarcinoma cells in vitro

KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer

Soy Isoflavone Genistein Impedes Cancer Stemness and Mesenchymal Transition in Head and Neck Cancer through Activating miR-34a/RTCB Axis

Therapeutic Inhibition of SGK1 Suppresses Colorectal Cancer

Genistein Inhibits Lung Cancer Cell Stem-Like Characteristics by Modulating MnSOD and FoxM1 Expression

Genistein Suppresses in Vitro Invasive Growth of Human Hepatocellular Carcinoma Cells

Antitumor and immunomodulatory activity of genkwanin on colorectal cancer in the APC(Min/+) mice

An analysis of the clinical significance of the TKI-resistant gene ZNF687 for hepatocellular carcinoma patients

The Effects of Two Tyrosine Kinase Inhibitors on the Proliferation of Colon Cancer Cell